vancomycin has been researched along with eperezolid in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (64.29) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbachyn, MR; Brickner, SJ; Ford, CW; Garmon, SA; Grega, KC; Hendges, SK; Hutchinson, DK; Manninen, PR; Toops, DS; Ulanowicz, DA; Zurenko, GE | 1 |
| Chu, DT; Katz, L; Plattner, JJ | 1 |
| Adams, WJ; Allwine, DA; Emmert, DE; Ford, CW; Friis, JM; Garmon, SA; Genin, MJ; Hamel, JC; Hester, JB; Hutchinson, DK; Schaadt, RD; Shobe, EM; Stapert, D; Yagi, BH; Zurenko, GE | 1 |
| Cho, YS; Choi, JH; Choi, KI; Joo, HJ; Kim, BH; Kim, HY; Koh, HY; Pae, AN | 1 |
| Allwine, DA; Anderson, DJ; Barbachyn, MR; Emmert, DE; Ford, CW; Garmon, SA; Genin, MJ; Graber, DR; Grega, KC; Hamel, JC; Hester, JB; Hutchinson, DK; Morris, J; Reischer, RJ; Schaadt, RD; Stapert, D; Yagi, BH; Zurenko, GE | 1 |
| Airault, M; Benedetti, Y; Bonnefoy, A; Chatreaux, F; Demassey, J; Dupuis-Hamelin, C; Ferroud, D; Haesslein, JL; Iltis, A; Khider, J; Klich, M; Lachaud, S; Lassaigne, P; Laurin, P; Musicki, B; Periers, AM; Pierre, C; Tessot, N; Vicat, P | 1 |
| Barbachyn, MR; Brickner, SJ; Hutchinson, DK; Manninen, PR | 1 |
| Barbachyn, MR; Brickner, SJ; Ford, CW; Hamel, JC; Hutchinson, DK; Moerman, JK; Stapert, D; Wilson, DM; Yancey, RJ | 1 |
| Allison, JW; Barbachyn, MR; Brickner, SJ; Glickman, SE; Hutchinson, DK; Kilburn, JO; Schaadt, RD; Yagi, BH; Zurenko, GE | 1 |
| Kaatz, GW; Seo, SM | 1 |
| Aeschlimann, JR; Cappelletty, DM; Kaatz, GW; Moldovan, T; Rybak, MJ | 1 |
| Eliopoulos, GM; Moellering, RC; Schülin, T; Thauvin-Eliopoulos, C | 1 |
| Colleran, E; Cormican, M; Curtin, J; Fleming, G; Keelehan, J | 1 |
| Kapadnis, PB; Lohray, BB; Lohray, VB; Pandya, P; Srivastava, BK | 1 |
2 review(s) available for vancomycin and eperezolid
| Article | Year |
|---|---|
New directions in antibacterial research.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Molecular Sequence Data; Molecular Structure | 1996 |
Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones | 2008 |
12 other study(ies) available for vancomycin and eperezolid
| Article | Year |
|---|---|
Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections.
Topics: Acetamides; Animals; Anti-Infective Agents; Dogs; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Linezolid; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Rats | 1996 |
Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Haemophilus influenzae; Inhibitory Concentration 50; Injections, Intravenous; Male; Mice; Moraxella catarrhalis; Oxazoles; Pyrazoles; Pyrroles; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Structure-Activity Relationship | 1998 |
Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles.
Topics: Anti-Bacterial Agents; Gram-Positive Bacteria; Isoxazoles; Microbial Sensitivity Tests; Oxazoles | 1999 |
Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Azoles; Haemophilus influenzae; Humans; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Moraxella catarrhalis; Oxazoles; Structure-Activity Relationship | 2000 |
Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Coumarins; Hexoses; Microbial Sensitivity Tests | 2000 |
In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections.
Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Injections, Intravenous; Injections, Subcutaneous; Linezolid; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus aureus; Vancomycin | 1996 |
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Vancomycin | 1996 |
In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Oxazoles; Oxazolidinones; Penicillins; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Vancomycin | 1996 |
Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Ente
Topics: Acetamides; Anti-Bacterial Agents; Coagulase; Enterococcus faecalis; Enterococcus faecium; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus aureus; Vancomycin | 1998 |
Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.
Topics: Abdominal Abscess; Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Linezolid; Male; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vancomycin | 1999 |
Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections.
Topics: Acetamides; Anti-Infective Agents; Biofilms; Catheterization, Central Venous; Catheters, Indwelling; Colony Count, Microbial; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Sodium Chloride; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2003 |
Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Linezolid; Methicillin; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Pyridines; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 2004 |